Factors Influencing the Dose to Rectum During the Treatment of Prostate Cancer with IMRT Nandanuri M.S. Reddy, PhD, Brij M. Sood, MD, and Dattatreyudu.

Slides:



Advertisements
Similar presentations
RapidArc in Bergen Britt Nygaard, Harald Valen and Ellen Wasbø
Advertisements

Biologiske modeller i stråleterapi Dag Rune Olsen, The Norwegian Radium Hospital, University of Oslo.
Anatomy-based MLC Field Optimization for the Treatment of Gynecologic Malignancies Myriam Bouchard M.D. Nadeau S, Germain I, Raymond P.E., Harel F, Beaulieu.
Predicting the parameters of a prostate IMRT objective function based on dose statistics under fixed parameter settings Renzhi Lu, Richard J. Radke 1,
Pre-TME era. Mesorectal subsite/LN ALWAYS included in CTV Mesorectal subsite / LN region.
‘A little to a lot or a lot to a little’ ­ the crucial question to be raised in conformal radiation therapy Professor Dag Rune Olsen, PhD Institute for.
Understanding Radiotherapy-Induced Second Cancers
The Health Roundtable 1-1b_HRT1215-Session_HEGI_JOHNSON_WESTMEAD_NSW Volumetric Modulated Arc Therapy for Stereotactic Body Radiotherapy in Early Lung.
Clinical application of TCP ・ NTCP. Lyman JT. Complication probability as assessed from dosevolume histograms. Radiat Res Suppl 1985; 8:S13–S19. Because.
Radiotherapy Planning for Esophageal Cancers Parag Sanghvi, MD, MSPH 9/12/07 Esophageal Cancer Tumor Board Part 1.
Dosimetric Evaluation of Planning Techniques in Lung SBRT
IMRT for the Treatment of Anal Cancer Kristen O’Donnell, MS3 December 12, 2007.
Measurement of Dose to Critical Structures Surrounding the Prostate from Intensity-Modulated Radiation Therapy (IMRT) and Three Dimensional Conformal Radiation.
Comparison of Rectal Dose Volume Histograms for Definitive Prostate Radiotherapy Among Stereotactic Radiotherapy, IMRT, and 3D-CRT Techniques Author(s):
Comparison Of Two Contouring Methods Of Bone Marrow On CT & Correlation With Hematological Toxicities (HT) In Non Bone Marrow Sparing Pelvic IMRT (NBM-IMRT)
H Ariyaratne1,2, H Chesham2, J Pettingell2, K Sikora2, R Alonzi1,2
Parameter selection in prostate IMRT Renzhi Lu, Richard J. Radke 1, Andrew Jackson 2 Rensselaer Polytechnic Institute 1,Memorial Sloan-Kettering Cancer.
Predictive models validated by clinical data: new strategies for fractionation Dr. M. Benassi Dr. S. Marzi.
Region of Interest Analysis as a Tool for Exploring Adaptive IMRT Strategy for Cervix Cancer Patients Young-Bin Cho 1,2, Valerie Kelly 1, Karen Lim 1,2,
CTOS Soft Tissue Sarcoma of the Extremity Comparison of Conformal Post-operative Radiotherapy (CRT) and Intensity Modulated Radiotherapy (IMRT)
Clinico-Dosimetric Correlation for Acute and Chronic Gastrointestinal Toxicity in Patients of Locally Advanced Carcinoma Cervix Treated With Conventional.
Quantitative Dosimetric Analysis Of Patterns Of Local Relapse After IMRT For Primary Extremity Soft Tissue Sarcomas Ryan M. Lanning, Sean L. Berry, Michael.
Validity of more than 30Gy radiation therapy for long-surviving patients with painful bone metastases E.Katayama 1,2, H.Okada 1, I.Asakawa 2, T.Tamamoto.
PROSTATE CANCER: RADIATION THERAPY APPROACHES ANDREW L. SALNER, MD FACR DIRECTOR HELEN & HARRY GRAY CANCER CENTER HARTFORD HOSPITAL, CT.
RESULTS 4D-Computed Tomography Guided Treatment Planning for Intrahepatic Tumors Yen-Lin Chen, M.D. 1,2, Eike Rietzel, Ph.D. 1,2, Judith Adams 1,2, John.
Medical considerations to guide mixed integer formulations of IMRT planning problems from MD to NP to CR Mark Langer, MD Radiation Oncology Indiana University.
Investigation of 3D Dosimetry for an Anthropomorphic Spine Phantom R. Grant 1,2, G. Ibbott 1, J. Yang 1, J. Adamovics 3, D Followill 1 (1)M.D. Anderson.
A Tumour Control Probability based approach to the development of Plan Acceptance Criteria for Planning Target Volume in Intensity Modulated Radiation.
Hormone treatment combined with radiotherapy
Purpose and Objectives: To investigate
Optimization of Volumetric Modulated Arc Therapy (VMAT) Planning Strategy Using Ring-shaped ROI for Localized Prostate cancer Kentaro Ishii, Masako Hosono,
Karolina Kokurewicz Supervisors: Dino Jaroszynski, Giuseppe Schettino
Saad El Din I, M.D *, Abd El AAl H, M.D *, Makaar W, M.D *, El Beih D, M.Sc †, Hashem W, M.Sc * *Department of Clinical Oncology and Radiotherapy, Kasr.
Stereotactic Body Radiation Therapy for Early Stage Prostate Cancer: Outcomes from a Single Institution Study Stereotactic Body Radiation Therapy for Early.
The use of Radiotherapy in Cancer.. What is radiotherapy? The treatment of cancer with ionising radiation is called Radiotherapy or Radiation Oncology.
References : [1] Hurkmans CW, et al Set-up verification using portal imaging; review of current clinical practice. Radiother. Oncol. 2001;58: [2]
A comparison between soft tissue and bone registration techniques for prostate radiotherapy Richard Small, Paul Bartley, Audrey Ogilvie, Nick West and.
Taipei Veterans General Hospital Practices Guidelines Oncology Rectal Cancer Version
Beam specific PTV incorporating 4DCT for PBS proton therapy of thoracic tumors Minglei Kang, PhD Authors: Liyong Lin1*, Minglei Kang1*, Sheng Huang1,
Incidence of Late Rectal and Urinary Toxicities After Three-Dimensional Conformal Radiotherapy and Intensity-Modulated Radiotherapy for Localized Prostate.
Modern Radiation Oncology
Baseline Respiratory Parameters Documented
Feasibility of hippocampal sparing radiation therapy for glioblastoma using helical Tomotherapy Dr Kamalram THIPPU JAYAPRAKASH1,2,3, Dr Raj JENA1,4 and.
Introduction Materials & Methods Results Conclusion
Evaluation Of RTOG Guidelines For Monte Carlo Based Lung SBRT Planning
Introduction and Objectives
*Can the volume predict the acute reactions ?
Quality of treatment plans and accuracy of in vivo portal dosimetry in hybrid intensity- modulated radiation therapy and volumetric modulated arc therapy.
Dr Gemma Eminowicz Consultant Clinical Oncologist, UCLH, London
Correlation between urinary dose and delayed radiation cystitis after 78Gy intensity- modulated radiotherapy for high-risk prostate cancer: A 10-year follow-up.
CONTACT Catalina A. Riley
Fig. 4. Percentage of passing rate between clinical and 544 plans.
Reducing Treatment Time and MUs by using Dynamic Conformal Arc Therapy for SBRT Breath-Hold Patients Timothy Miller, Sebastian Nunez Albermann, Besil Raju,
Impact of magnetic resonance imaging on computed tomography-based treatment planning and acute toxicity for prostate cancer patients treated with intensity.
Volumetric Modulated Arc Therapy (VMAT) versus Intensity Modulated Radiation Therapy (IMRT) for Anal Carcinoma Heather Ortega, BSRT(T), CMD, Kerry Hibbitts,
Insert tables Insert graphs Insert figure
Figure 4 Dosimetric comparison of LDR‑BT versus HDR‑BT
Dosimetric Benefits and Practical Pitfalls of Daily Online Adaptive MRI-Guided Stereotactic Radiation Therapy for Pancreatic Cancer  Nancy El-Bared, MD,
Physics and Imaging in Radiation Oncology
ML 291 Rev. A.
Cone beam computed tomography-based monitoring and management of target and organ motion during external beam radiotherapy in cervical cancer  Nina Boje.
Clinical and radiobiological evaluation of a method for planning target volume generation dependent on organ-at-risk exclusions in magnetic resonance.
Figure 3 Target volume definitions
Clinical implementation of magnetic resonance imaging guided adaptive radiotherapy for localized prostate cancer  Shyama U. Tetar, Anna M.E. Bruynzeel,
Technical Innovations and Patient Support in Radiation Oncology
Constantinos Zamboglou, Matthias Eiber, Thomas R
Hydrogel spacer distribution within the perirectal space in patients undergoing radiotherapy for prostate cancer: Impact of spacer symmetry on rectal.
Planning techniques of proton boost
Hydrogel spacer distribution within the perirectal space in patients undergoing radiotherapy for prostate cancer: Impact of spacer symmetry on rectal.
Stereotactic Body Radiotherapy for Central Lung Tumors
Presentation transcript:

Factors Influencing the Dose to Rectum During the Treatment of Prostate Cancer with IMRT Nandanuri M.S. Reddy, PhD, Brij M. Sood, MD, and Dattatreyudu Nori, MD, FACR. Radiation Oncology, NY Hospital Queens, Flushing, NY

Purpose/Objective: 3D conformal radiotherapy (3D CRT) had shown that smaller the volume of rectum higher is the dose to rectum and vice versa (1-5). In addition, patients with small rectal wall volumes have been shown to be at a higher risk for rectal bleeding than patients with larger rectal wall volumes (1,2). Volumes of whole rectum (rectum + fillings) and rectal wall (whole rectum - fillings) vary from patient to patient. Whole rectal volumes varied from 50 to 250 cc (5), and rectal wall volumes varied from 12 to 44 cc (5), 18 to 97 cc (1), 30 to 130 cc (2). Purpose/Objective: 3D conformal radiotherapy (3D CRT) had shown that smaller the volume of rectum higher is the dose to rectum and vice versa (1-5). In addition, patients with small rectal wall volumes have been shown to be at a higher risk for rectal bleeding than patients with larger rectal wall volumes (1,2). Volumes of whole rectum (rectum + fillings) and rectal wall (whole rectum - fillings) vary from patient to patient. Whole rectal volumes varied from 50 to 250 cc (5), and rectal wall volumes varied from 12 to 44 cc (5), 18 to 97 cc (1), 30 to 130 cc (2).

However, with the inverse treatment planning, the dose-volume constraints placed on rectum are such that the 70, 50, and 30% volumes of rectum should not receive more than 40, 60 and 70% of the prescription dose, respectively. However, this type of dose-volume constraints do not take into account of the variation in the rectal volumes among patients.

In this report, we have examined the relationship between dose to 70, 50 and 30% volumes of whole rectum or rectal wall vs. volumes of whole rectum and rectal wall. We also evaluated the relationship between dose per cc at 70, 50 and 30% of the volumes of whole rectum or rectal wall vs. volumes of whole rectum or rectal wall. This analysis might help to better understand the relationship between dose per cc of whole rectum or rectal wall vs. potential rectal toxicity.

Materials/Methods: Prostate, SV, whole rectum (with fillings = WR), rectal wall only (WR– fillings=RW) and bladder were contoured for 21 patients (Fig. 1). The caudal limit of rectum was the first slice above the anal verge and the cranial limit was first slice below the sigmoid flexure (Fig. 2). Variation in the delineation of rectum at the cranial end could have occurred, up to 10%, for two main reasons: 1) presence of air and fecal matter in rectum (Fig. 3), which makes it difficult to discern the sigmoid flexure at S3, and the presence of unusually large amounts of bowels in pelvis, (Fig. 4), which makes it difficult to differentiate the rectum from bowels. Materials/Methods: Prostate, SV, whole rectum (with fillings = WR), rectal wall only (WR– fillings=RW) and bladder were contoured for 21 patients (Fig. 1). The caudal limit of rectum was the first slice above the anal verge and the cranial limit was first slice below the sigmoid flexure (Fig. 2). Variation in the delineation of rectum at the cranial end could have occurred, up to 10%, for two main reasons: 1) presence of air and fecal matter in rectum (Fig. 3), which makes it difficult to discern the sigmoid flexure at S3, and the presence of unusually large amounts of bowels in pelvis, (Fig. 4), which makes it difficult to differentiate the rectum from bowels.

The prescription was 45 Gy to prostate and SV in 25 fractions (Prostate + SV=CTV, CTV + margin = PTV) with 5F IMRT 6plans. Dose to 30, 50 and 70% of whole rectum and rectal wall were estimated from the DVH. In addition, dose to 1 cc at 30, 50 and 70% volumes of whole rectum or rectal wall were. At a given % volume level, the dose to that % volume was divided by the % volume in cc of the whole rectum or rectal wall. The resulting value is expressed as dose per cc at 30, 50 and 70% volumes. These data were plotted against the volumes of whole rectum or rectal wall. Pearson’s correlation coefficient ‘r’ and the two-tailed P values were estimated.

Results: The volume of whole rectum varied from 25 to 177 cc between patients (Fig. 5). Larger the volume of whole rectum, larger was also the volume of rectal wall (Fig. 5, 18-68cc, P<0.01). Dose to rectal wall was less in 10 patients by 6- 21% at 50% volume, compared to doses to whole rectum. This difference in doses seen for large whole rectum volumes decreased beyond 20% volume and disappeared below 10% volume (Fig. 6). Results: The volume of whole rectum varied from 25 to 177 cc between patients (Fig. 5). Larger the volume of whole rectum, larger was also the volume of rectal wall (Fig. 5, 18-68cc, P<0.01). Dose to rectal wall was less in 10 patients by 6- 21% at 50% volume, compared to doses to whole rectum. This difference in doses seen for large whole rectum volumes decreased beyond 20% volume and disappeared below 10% volume (Fig. 6).

Dose to 30%, 50% or 70% volumes of whole rectum (Fig. 7) or rectal wall (Fig. 8, except at 50% volume, P 0.2). This was because the same dose-volume constraints were placed on whole rectum independent of variations in whole rectum volumes between patients. However, smaller the volume of rectum, higher was the dose per cc of whole rectum (Fig. 9 and 10) or rectal wall (Fig. 11 and 12) and vice versa (p 0.2). This was because the same dose-volume constraints were placed on whole rectum independent of variations in whole rectum volumes between patients. However, smaller the volume of rectum, higher was the dose per cc of whole rectum (Fig. 9 and 10) or rectal wall (Fig. 11 and 12) and vice versa (p<0.001). This was due to the fact that dose per cc takes into account of the variations in the volume of whole rectum or rectal wall between patients.

Dose conformity to PTV and dose to rectum were interrelated and the resulting IMRT plan was a combination a trade of between dose to rectum and dose conformity to PTV. When the volume of rectum was small, dose-volume constraints (DVC) for rectum could only be achieved at the expense of dose conformity to the PTV. For example, in the case of a rectum with a volume of 25 cc, rectal dose to 30 % volume was 35 Gy for PTV coverage of % of prescription dose (heterogeneity index (HI), max/min, = 1.19). Conversely, for a rectal dose of 31.8 Gy to 30% volume, the dose coverage to PTV was % of the prescription dose (HI = 1.47).

Conclusions: Rectal volumes vary from patient to patient. Larger the volume of whole rectum, larger was also the volume of rectal wall. In IMRT, as in the case of 3D, patients with smaller rectal volumes would be at a higher risk for rectal toxicity because dose delivered to per cc of rectum increases with the decrease in the volume of rectum. Therefore, it is suggested that: 1) dose per cc of rectum in addition to the doses to 30, 50 and 70% volumes may be used to predict rectal toxicity more reliably and, 2) that the use of rectal wall volumes to express dose to rectum would be more accurate and reliable because rectal wall volume changes due to rectal fillings would be minimal.

References: 1. M.W. Skwarchuk et. al. Int. J. Radiat. Oncol. Biol. Phys. 47, , A. Jackson et. al. Int. J. Radiat. Oncol. Biol. Phys. 49, , E.H. Huang et. al. Int. J. Radiat. Oncol. Biol. Phys. 54, , N. Reddy et. al. Med. Phys. 30, 1505, P.C.M. Koper et. al. Int. J. Radiat. Oncol. Biol. Phys. 58, , 2004 References: 1. M.W. Skwarchuk et. al. Int. J. Radiat. Oncol. Biol. Phys. 47, , A. Jackson et. al. Int. J. Radiat. Oncol. Biol. Phys. 49, , E.H. Huang et. al. Int. J. Radiat. Oncol. Biol. Phys. 54, , N. Reddy et. al. Med. Phys. 30, 1505, P.C.M. Koper et. al. Int. J. Radiat. Oncol. Biol. Phys. 58, , 2004

Whole rectum Rectal Wall Rectal Fillings

Bladder Rectum Prostate SV Sigmoid flexure S3

Rectum Bowels